Key Takeaways
- • Crossover hedge funds face sustained headwinds in private markets: Tiger Global, Coatue, Viking, and similar funds that aggressively deployed capital into startups in 2020-2021 experienced a dramatic slowdown in 2023, with the Forge Global Index (tracking major unicorns) declining 20% in 2023 following a 44% drop in 2022.
- • SurgoCap Partners' limited activity signals broader private-market paralysis: The $1.8 billion fund launched by former Lone Pine managing director Mala Gaonkar—the largest-ever hedge fund launch by a woman—made only a single private investment since inception, and key personnel including Jason Kong departed within months, reflecting reduced appetite for private-market commitments.
- • Interest-rate hikes and credit stress triggered market reset: Federal Reserve rate increases combined with the 2023 banking crisis (including Silicon Valley Bank's collapse) ground private-market activity to a halt, particularly affecting crossover funds that simultaneously invest in public and private securities.
- • Market participants express cautious optimism for 2024 recovery: Despite 2023's "hibernation," industry commentary suggests potential market thaw ahead, though sustainable recovery remains contingent on interest-rate stabilization and renewed valuations in secondary private-market indices.
Summary
The private-markets investment landscape experienced severe contraction throughout 2023 after two years of exuberant capital deployment by crossover hedge funds. Firms including Tiger Global, Coatue, and Viking, which had aggressively funded startup ecosystems during 2020-2021, largely retreated from new commitments as macroeconomic conditions deteriorated. This pullback is exemplified through the trajectory of SurgoCap Partners, which launched in early 2023 with $1.8 billion in assets under management—marking the largest-ever hedge fund launch led by a woman manager, former Lone Pine Capital managing director Mala Gaonkar. Despite positioning itself to invest across both public and private markets, SurgoCap has deployed capital into only a single private investment since launch, indicating the magnitude of market dysfunction affecting even well-capitalized new entrants.
Personnel departures underscore the sector's challenges. Jason Kong, a former IVP partner and 2021 Forbes 30 Under 30 venture capital honoree who was expected to lead SurgoCap's private-market initiatives, left the firm within months to join VC firm Base10. Such exits reflect not only reduced capital allocation opportunities but also diminished career prospects within funds facing constrained deployment pipelines.
The immediate catalyst for market paralysis was the cumulative effect of aggressive interest-rate increases implemented by global central banks throughout 2022 and into 2023. These rate hikes, compounded by the March 2023 collapse of Silicon Valley Bank—a primary lender to technology startups and venture capital firms—created a cascading credit crunch that effectively halted fundraising and acquisition activity across the private-markets ecosystem. According to Pitchbook's venture capital outlook, market conditions remained "just slow" with a "market reset in progress" throughout the period.
Quantitative evidence of valuation deterioration is substantial. The Forge Global Index, which tracks secondary market pricing for dozens of major unicorns in real time, declined approximately 20% during 2023 following a steeper 44% contraction in 2022. This two-year cumulative decline signals not merely cyclical correction but structural repricing of private-market assets that had become significantly overvalued during the 2020-2021 capital abundance period.
Despite 2023's challenging environment, market participants and industry observers have begun signaling cautious optimism regarding potential recovery in 2024. However, sustained improvement remains dependent on stabilization in interest-rate policy and renewed investor confidence in private-market valuations, conditions that remain uncertain.
Personnel departures underscore the sector's challenges. Jason Kong, a former IVP partner and 2021 Forbes 30 Under 30 venture capital honoree who was expected to lead SurgoCap's private-market initiatives, left the firm within months to join VC firm Base10. Such exits reflect not only reduced capital allocation opportunities but also diminished career prospects within funds facing constrained deployment pipelines.
The immediate catalyst for market paralysis was the cumulative effect of aggressive interest-rate increases implemented by global central banks throughout 2022 and into 2023. These rate hikes, compounded by the March 2023 collapse of Silicon Valley Bank—a primary lender to technology startups and venture capital firms—created a cascading credit crunch that effectively halted fundraising and acquisition activity across the private-markets ecosystem. According to Pitchbook's venture capital outlook, market conditions remained "just slow" with a "market reset in progress" throughout the period.
Quantitative evidence of valuation deterioration is substantial. The Forge Global Index, which tracks secondary market pricing for dozens of major unicorns in real time, declined approximately 20% during 2023 following a steeper 44% contraction in 2022. This two-year cumulative decline signals not merely cyclical correction but structural repricing of private-market assets that had become significantly overvalued during the 2020-2021 capital abundance period.
Despite 2023's challenging environment, market participants and industry observers have begun signaling cautious optimism regarding potential recovery in 2024. However, sustained improvement remains dependent on stabilization in interest-rate policy and renewed investor confidence in private-market valuations, conditions that remain uncertain.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.